Vaginal microbiota and human papillomavirus infection among young Swedish women.


Journal

NPJ biofilms and microbiomes
ISSN: 2055-5008
Titre abrégé: NPJ Biofilms Microbiomes
Pays: United States
ID NLM: 101666944

Informations de publication

Date de publication:
12 10 2020
Historique:
received: 20 03 2020
accepted: 10 09 2020
entrez: 13 10 2020
pubmed: 14 10 2020
medline: 29 5 2021
Statut: epublish

Résumé

Human papillomavirus (HPV) infection is one of the most common sexually transmitted diseases. To define the HPV-associated microbial community among a high vaccination coverage population, we carried out a cross-sectional study with 345 young Swedish women. The microbial composition and its association with HPV infection, including 27 HPV types, were analyzed. Microbial alpha-diversity was found significantly higher in the HPV-infected group (especially with oncogenic HPV types and multiple HPV types), compared with the HPV negative group. The vaginal microbiota among HPV-infected women was characterized by a larger number of bacterial vaginosis-associated bacteria (BVAB), Sneathia, Prevotella, and Megasphaera. In addition, the correlation analysis demonstrated that twice as many women with non-Lactobacillus-dominant vaginal microbiota were infected with oncogenic HPV types, compared with L. crispatus-dominated vaginal microbiota. The data suggest that HPV infection, especially oncogenic HPV types, is strongly associated with a non-Lactobacillus-dominant vaginal microbiota, regardless of age and vaccination status.

Identifiants

pubmed: 33046723
doi: 10.1038/s41522-020-00146-8
pii: 10.1038/s41522-020-00146-8
pmc: PMC7552401
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

39

Références

Bruni, L. et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect. Dis. 202, 1789–1799 (2010).
pubmed: 21067372 doi: 10.1086/657321
Smith, J. S., Melendy, A., Rana, R. K. & Pimenta, J. M. Age-specific prevalence of infection with human papillomavirus in females: a global review. J. Adolesc. Health 43, S5–S25 (2008).
pubmed: 18809145 doi: 10.1016/S1054-139X(08)00317-0
Lehtinen, M., Baussano, I., Paavonen, J., Vänskä, S. & Dillner, J. Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies. Expert Rev. Vaccines 18, 153–160 (2019).
pubmed: 30657348 doi: 10.1080/14760584.2019.1568876
Muñoz, N. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl. J. Med. 348, 518–527 (2003).
pubmed: 12571259 doi: 10.1056/NEJMoa021641
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N. & Franceschi, S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88, 63–73 (2003).
pubmed: 12556961 pmcid: 2376782 doi: 10.1038/sj.bjc.6600688
Du, J., Näsman, A., Carlson, J. W., Ramqvist, T. & Dalianis, T. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination. Acta Oncol. 50, 1215–1219 (2011).
pubmed: 21726177 doi: 10.3109/0284186X.2011.584556
Ährlund-Richter, A. et al. Changes in cervical human papillomavirus (HPV) prevalence at a youth clinic in stockholm, sweden, a decade after the introduction of the HPV vaccine. Front. Cell. Infect. Microbiol. 9, 59 (2019).
pubmed: 30949454 pmcid: 6435486 doi: 10.3389/fcimb.2019.00059
Grün, N. et al. Follow-up on oral and cervical human papillomavirus prevalence 2013-2015 in youth at a youth clinic in Stockholm, Sweden. Infect. Dis. 48, 169–170 (2016).
doi: 10.3109/23744235.2015.1094573
Ramqvist, T. et al. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden. Scand. J. Infect. Dis. 43, 115–121 (2011).
pubmed: 20964488 doi: 10.3109/00365548.2010.526957
Chaban, B. et al. Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome 2, 23 (2014).
pubmed: 25053998 pmcid: 4106219 doi: 10.1186/2049-2618-2-23
Fettweis, J. M. et al. The vaginal microbiome and preterm birth. Nat. Med. 25, 1012–1021 (2019).
pubmed: 31142849 pmcid: 6750801 doi: 10.1038/s41591-019-0450-2
Mitra, A. et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome 4, 58 (2016).
pubmed: 27802830 pmcid: 5088670 doi: 10.1186/s40168-016-0203-0
Onderdonk, A. B., Delaney, M. L. & Fichorova, R. N. The human microbiome during bacterial vaginosis. Clin. Microbiol. Rev. 29, 223–238 (2016).
pubmed: 26864580 pmcid: 4786887 doi: 10.1128/CMR.00075-15
Brotman, R. M. et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J. Infect. Dis. 210, 1723–1733 (2014).
pubmed: 24943724 pmcid: 4296189 doi: 10.1093/infdis/jiu330
Petrova, M. I., van den Broek, M., Balzarini, J., Vanderleyden, J. & Lebeer, S. Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiol. Rev. 37, 762–792 (2013).
pubmed: 23789590 doi: 10.1111/1574-6976.12029
DiGiulio, D. B. et al. Temporal and spatial variation of the human microbiota during pregnancy. Proc. Natl Acad. Sci. USA 112, 11060–11065 (2015).
pubmed: 26283357 doi: 10.1073/pnas.1502875112
Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108, 4680–4687 (2011).
pubmed: 20534435 doi: 10.1073/pnas.1002611107
Serrano, M. G. et al. Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy. Nat. Med. 25, 1001–1011 (2019).
pubmed: 31142850 pmcid: 6746180 doi: 10.1038/s41591-019-0465-8
Coleman, J. S. & Gaydos, C. A. Molecular diagnosis of bacterial vaginosis: an update. J. Clin. Microbiol. 56, e00342-18 (2018).
Fredricks, D. N., Fiedler, T. L. & Marrazzo, J. M. Molecular identification of bacteria associated with bacterial vaginosis. New Engl. J. Med. 353, 1899–1911 (2005).
pubmed: 16267321 doi: 10.1056/NEJMoa043802
Oakley, B. B., Fiedler, T. L., Marrazzo, J. M. & Fredricks, D. N. Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl. Environ. Microbiol. 74, 4898–4909 (2008).
pubmed: 18487399 pmcid: 2519371 doi: 10.1128/AEM.02884-07
Ugur, A. R., Tuncer, E. I. & Findik, D. Identification of bacterial vaginosis-associated bacteria in male urethra: Co-occurrence of Atopobium vaginae and Gardnerella vaginalis. Marshall J. Med. https://doi.org/10.21161/mjm.180025 (2019).
Huang, X. et al. Cervicovaginal microbiota composition correlates with the acquisition of high-risk human papillomavirus types. Int. J. Cancer 143, 621–634 (2018).
pubmed: 29479697 doi: 10.1002/ijc.31342
Norenhag, J. et al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. https://doi.org/10.1111/1471-0528.15854 (2019)
Brusselaers, N., Shrestha, S. A. D. E. E. P., van de Wijgert, J. A. N. N. E. K. E. & Verstraelen, H. A. N. S. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am. J. Obstet. Gynecol. 221, 9–18 (2019).
pubmed: 30550767 doi: 10.1016/j.ajog.2018.12.011
Mitra, A. et al. The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions. Nat. Commun. 11, 1999 (2020).
pubmed: 32332850 pmcid: 7181700 doi: 10.1038/s41467-020-15856-y
Curty, G. et al. Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions. Sci. Rep. 7, 17364 (2017).
pubmed: 29234019 pmcid: 5727204 doi: 10.1038/s41598-017-17351-9
Callahan, B. J. et al. Replication and refinement of a vaginal microbial signature of preterm birth in two racially distinct cohorts of US women. Proc. Natl Acad. Sci. USA 114, 9966–9971 (2017).
pubmed: 28847941 doi: 10.1073/pnas.1705899114
Łaniewski, P. et al. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci. Rep. 8, 7593 (2018).
pubmed: 29765068 pmcid: 5954126 doi: 10.1038/s41598-018-25879-7
Di Paola, M. et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci. Rep. 7, 10200 (2017).
pubmed: 28860468 pmcid: 5579045 doi: 10.1038/s41598-017-09842-6
Godoy-Vitorino, F. I. L. I. P. A. et al. Cervicovaginal fungi and bacteria associated with cervical intraepithelial neoplasia and high-risk human papillomavirus infections in a hispanic population. Front. Microbiol. 9, 2533 (2018).
pubmed: 30405584 pmcid: 6208322 doi: 10.3389/fmicb.2018.02533
Shannon, B. et al. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal Immunol. 10, 1310–1319 (2017).
pubmed: 28120845 pmcid: 5526752 doi: 10.1038/mi.2016.129
Hugerth, L. W. et al. A comprehensive automated pipeline for human microbiome sampling, 16S rRNA gene sequencing and bioinformatics processing. BioRxiv https://doi.org/10.1101/286526 (2018).
Nordfors, C. et al. Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer. Oral Oncol. 50, 491–497 (2014).
pubmed: 24613649 doi: 10.1016/j.oraloncology.2014.02.012
Dalianis, T. et al. Human papillomavirus DNA and p16(INK4a) expression in hypopharyngeal cancer and in relation to clinical outcome, in Stockholm, Sweden. Oral Oncol. 51, 857–861 (2015).
pubmed: 26120094 doi: 10.1016/j.oraloncology.2015.06.002
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10 (2011).
doi: 10.14806/ej.17.1.200
Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
pubmed: 27214047 pmcid: 27214047 doi: 10.1038/nmeth.3869
Davis, N. M., Proctor, D. M., Holmes, S. P., Relman, D. A. & Callahan, B. J. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome 6, 226 (2018).
pubmed: 30558668 pmcid: 6298009 doi: 10.1186/s40168-018-0605-2
Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2013).
pubmed: 23193283 doi: 10.1093/nar/gks1219
Zhang, Z., Schwartz, S., Wagner, L. & Miller, W. A greedy algorithm for aligning DNA sequences. J. Comput. Biol. 7, 203–214 (2000).
pubmed: 10890397 doi: 10.1089/10665270050081478
NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 44, D7–D19 (2016).
doi: 10.1093/nar/gkv1290
Holm, J. B. et al. Comparative metagenome-assembled genome analysis of Lachnovaginosum genomospecies, formerly known as BVAB1. BioRxiv https://doi.org/10.1101/657197 (2019).
Austin, M. N. et al. Mageeibacillus indolicus gen. nov., sp. nov.: a novel bacterium isolated from the female genital tract. Anaerobe 32, 37–42 (2015).
pubmed: 25482717 doi: 10.1016/j.anaerobe.2014.12.003
Hyman, R. W. et al. Diversity of the vaginal microbiome correlates with preterm birth. Reprod. Sci. 21, 32–40 (2014).
pubmed: 23715799 pmcid: 3857766 doi: 10.1177/1933719113488838
Hyman, R. W. et al. Microbes on the human vaginal epithelium. Proc. Natl Acad. Sci. USA 102, 7952–7957 (2005).
pubmed: 15911771 doi: 10.1073/pnas.0503236102
Ferris, M. J., Masztal, A. & Martin, D. H. Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis. J. Clin. Microbiol. 42, 5892–5894 (2004).
pubmed: 15583334 pmcid: 535275 doi: 10.1128/JCM.42.12.5892-5894.2004
Zhou, X. et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J. 1, 121–133 (2007).
pubmed: 18043622 doi: 10.1038/ismej.2007.12
Hoyles, L., Collins, M. D., Falsen, E., Nikolaitchouk, N. & McCartney, A. L. Transfer of members of the genus Falcivibrio to the genus Mobiluncus, and emended description of the genus Mobiluncus. Syst. Appl. Microbiol. 27, 72–83 (2004).
pubmed: 15053324 doi: 10.1078/0723-2020-00260
Zozaya-Hinchliffe, M., Lillis, R., Martin, D. H. & Ferris, M. J. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J. Clin. Microbiol. 48, 1812–1819 (2010).
pubmed: 20305015 pmcid: 2863870 doi: 10.1128/JCM.00851-09

Auteurs

Liqin Cheng (L)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.

Johanna Norenhag (J)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Yue O O Hu (YOO)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.

Nele Brusselaers (N)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.

Emma Fransson (E)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Andreas Ährlund-Richter (A)

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

Unnur Guðnadóttir (U)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.

Pia Angelidou (P)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.

Yinghua Zha (Y)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.

Marica Hamsten (M)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.

Ina Schuppe-Koistinen (I)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.
Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.

Matts Olovsson (M)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Lars Engstrand (L)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.
Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.

Juan Du (J)

Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden. juan.du@ki.se.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH